First, insulin-like growth factor-binding protein 3 (IBP3) has been reported to be a lung cancer biomarker in serum, bronchoalveolar lavage fluid and lung tissue35–37 and has also been reported to modulate lung tumorigenesis38. This evidence concerns the gene IGFBP3 and lung carcinoma.